Wells Fargo & Company Bio Restorative Therapies, Inc. Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.15 - $2.22 $592 - $1,143	-515 Reduced 34.8%	965 $1,000
Q1 2024 May 10, 2024	SELL	$1.28 - $3.45 $602 - $1,624	-471 Reduced 24.14%	1,480 $2,000
Q4 2023 Feb 09, 2024	SELL	$1.74 - $2.28 $12,865 - $16,858	-7,394 Reduced 79.12%	1,951 $3,000
Q3 2023 Nov 13, 2023	SELL	$1.45 - $4.57 $3,214 - $10,131	-2,217 Reduced 19.17%	9,345 $16,000
Q2 2023 Aug 15, 2023	BUY	$3.49 - $6.49 $40,274 - $74,894	11,540 Added 52454.55%	11,562 $50,000
Q4 2022 Feb 13, 2023	BUY	$2.58 - $3.68 $2 - $3	1 Added 4.76%	22 $0
Q3 2022 Nov 14, 2022	BUY	$2.46 - $3.47 $7 - $10	3 Added 16.67%	21 $0
Q2 2022 Aug 12, 2022	BUY	$2.95 - $5.85 $5 - $11	2 Added 12.5%	18 $0
Q1 2022 May 16, 2022	BUY	$3.3 - $5.69 $6 - $11	2 Added 14.29%	16 $0
Q4 2021 Feb 14, 2022	BUY	$4.02 - $18.0 $56 - $252	14 New	14 $0

270K

Ticker BRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,650,030
Market Cap $5.26M
Description
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.